DELTA 9 CANNABIS INC. provided guidance on select fourth quarter and year end results ending December 31, 2021, based on preliminary results:
- The Company anticipates net revenues for the three-month period ending December 31, 2021, to be between $16.6 million and $17.4 million. This compares with:
- $14.15 million for the same period in 2020, an increase of between 17% and 23%.
- $15.2 million sequentially from the third quarter of 2021, an increase of between 9% and 14%.
- The Company anticipates net revenues for the year ending December 31, 2021, to be between $61.8 million and $62.6 million, compared to $52.1 million for the same period in the prior year.
“We are anticipating reporting strong year-over-year and sequential revenue results for the fourth quarter of 2021,” said John Arbuthnot, CEO of Delta 9. “Delta 9 is working to differentiate itself from its peers by posting strong financial and operating results and continuing to grow its revenue streams from its three core business units.”
Delta 9 will provide investors with a full breakdown on its progress in these areas as a part of its year end and fourth quarter results which will be released on March 31, 2022, before markets open, followed by a conference call, details for which can be found at the end of this release.
The preliminary estimated financial results and other data for the three-month period and year ended December 31, 2021, set forth above are unaudited and subject to the completion of the Company’s financial closing procedures. These preliminary estimated financial results have been prepared by and are the responsibility of the Company’s management. The Company’s independent registered public accounting firm, Baker Tilly HMA LLP, is in the process of performing year-end audit procedures with respect to the accompanying preliminary financial results and other data, and accordingly does not express an opinion or any other form of assurance with respect thereto.
